Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
Desitin Arzneimittel Gmbh
🇳🇴
Norway
Country
🇳🇴
Norway
Ownership
Private
Established
1919-01-01
Employees
251
Market Cap
-
Website
http://www.desitin.de
Clinical Trials
Related News
SEDPARK1: Safety and Efficacy Study With the Non-ergot Dopamine-agonist Piribedil in Parkinson's Disease
Completed
Conditions
Parkinson's Disease
Subscribe
First Posted Date
2008-07-30
Last Posted Date
2010-03-31
Lead Sponsor
Desitin Arzneimittel GmbH
Target Recruit Count
250
Registration Number
NCT00725478
Subscribe
EXTENT: EXtended Tolerability and Efficacy of a Novel Formulation of Oxcarbazepine in a Trial in Partial Epilepsy
Phase 3
Terminated
Conditions
Partial Epilepsy
Interventions
Drug: modified release formulation of oxcarbazepine (OXC MR)
Drug: immediate release formulation of oxcarbazepine (OXC IR)
Subscribe
First Posted Date
2006-10-24
Last Posted Date
2010-04-15
Lead Sponsor
Desitin Arzneimittel GmbH
Target Recruit Count
100
Registration Number
NCT00391534
Subscribe
Prev
1
2
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy